Isosceles News

The Client This Isosceles client is a start-up in the defence sector. It develops systems to protect users and equipment, mainly for the UK but also for some NATO countries. It is currently pre-revenue but aims to grow significantly in the next five years.    The Requirement Ready for more cash funding via loans and investment, this client approached Isosceles for support from a fractional CFO to get them investment-ready. They … Continue reading →

As the business prepared for investment, the focus turned to strengthening investor confidence through enhanced financial clarity and structure. This work ultimately supported the company in securing an additional cash injection from existing investors, positioning it for continued growth. The Client This early-stage pre-revenue medical devices company has worked intensively alongside clinicians, engineers and scientists over the last 10 years to deliver high-performance, cost-effective medical device technology that meets the … Continue reading →

Isosceles has worked with investor-backed businesses for over 20 years, and many of our clients have benefitted from programmes backed by the British Business Bank but were unaware of the Bank’s involvement. We were, therefore, delighted to welcome Tracy Sherratt and Dr Sophie Dale-Black from the British Business Bank to our recent iFD Community event to explain the work of the UK’s most influential business bank and introduce us to some of the funding options … Continue reading →

PE carve outs can create or unlock value. However, separation can present as many challenges as opportunities for PE firms. The anticipated value will not be realised if the newly formed company lacks the infrastructure, resources, and talent to operate effectively and independently. Related article | CFO options for investors and their portfolio companies In this blog post, we introduce the fractional role of an experienced CFO to manage the … Continue reading →

Follow us on LinkedIn and Twitter. Written by Joao Futscher, Fractional CFO In December 2023, the Monetary Policy Committee (MPC) at the Bank of England voted by a majority of 6-3 to maintain Bank Rate at 5.25%. After ten years below 1%, since 2022, in efforts to tackle inflation levels only seen in the 1980s, the Bank rate has soared, and some analysts predict that it could get higher. (Source: … Continue reading →

Follow us on LinkedIn and Twitter. The economic environment of 2025 is as challenging for PE and VC firms as it is for those companies seeking investment. Having the option to appoint a part-time (or fractional) CFO who has worked with investor-backed portfolio companies before and can understand and anticipate the increased demands of an investor will almost certainly increase the probability of the investor making the return they expect. … Continue reading →

Follow us on LinkedIn. In the early days, Fintech startups were proud to disrupt the financial services sector, unconstrained by regulatory requirements, stating, “We are tech companies, not financial institutions”, with funding in bountiful supply. Fast forward to 2023, and the picture is now very different, where managing regulatory risk and obtaining funding are the two biggest challenges facing Fintechs. This blog explores the regulatory risk facing Fintechs and how … Continue reading →

Current economic turbulence has changed investment sentiment, and investors are, without a doubt, cautious, so obtaining investment in 2024 is difficult, but it’s not impossible. Related article | Flags for investment – is your business ready to fundraise? Through our discussions with investors, we have an up-to-date view of how and where they are currently investing and can answer the following top questions: How has the investment landscape changed in … Continue reading →

Follow us on LinkedIn. Cambridge Molecular Diagnostics Limited (SwiftDx) announces the launch of a new lateral flow test for the detection of Mycoplasma contamination. The innovative, easy-to-use, rapid test uses an adapted PCR method and provides accurate results within minutes, making it a valuable tool for laboratories and manufacturers in academia and the biotech and pharmaceutical industries. The test has been fully validated, including evaluation within the University of Cambridge. … Continue reading →

Follow us on LinkedIn for all the latest insights, exciting updates and iFD news. Contribution by Joao Futscher Uncertain economic conditions create a constellation of issues and challenges for businesses, but the impact of such difficulties on venture capital (VC) and private equity (PE) investors is often overlooked. Investment requires a degree of confidence, but turbulent economic and political conditions have made this even more difficult to achieve.   We explore how … Continue reading →